Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14279/31273
Title: | Investigation of biomarkers regarding their predictive value in the development of gestational diabetes mellitus. An overview | Authors: | Lazarou, Eleftheria Lambrinou, Ekaterini Kolokotroni, Ourania Metallinou, Dimitra Miltiadous, Panagiota Hadjigeorgiou, Eleni |
Major Field of Science: | Medical and Health Sciences | Field Category: | Clinical Medicine | Keywords: | Gestational diabetes mellitus;Pregnancy;Biomarkers;Prediction | Issue Date: | 2023 | Source: | European Journal of Midwifery, 2023, vol. 7, suppl. 1, articl. no. A109 | Volume: | 7 | Issue: | Supplement 1 | Journal: | European Journal of Midwifery | Abstract: | Introduction: Gestational diabetes mellitus (GDM) has been associated with various short- and long-term adverse perinatal outcomes for both mothers and their offspring. Its incidence is estimated to be 14% of all pregnancies worldwide. GDM screening and diagnosis delay as they take place between the 24th and 28th week of gestational age. Discordance among GDM diagnostic criteria has increased research interest regarding biomarkers since they may provide useful information when clinical and laboratory findings are still lacking. The present review provides evidence through an overview of biomarkers investigated in the blood of pregnant women early in pregnancy who subsequently developed GDM. Material and Methods: PubMed and Google Scholar were searched for articles published between 2010 – 2023. Key words ‘’gestational diabetes mellitus’’, ‘’biomarkers’’, ‘’biochemical markers’’, ‘’blood’’, ‘’serum’’, ‘’pregnancy’’, ‘’prediction’’ were used to identify relevant articles. Results: Totally, 12 studies were included. Sex hormone binding globulin (SHBG), Osteocalcin, Follistatin-like 3 (FSTL3), Malondialdehyde (MDA), Glutathione Peroxidase Activity (GPA), Triglyceride, YKL-40, microRNAs, plasma-glycated CD59 (pGCD59), Irisin and Ferritin have been investigated early in pregnancy in the blood of pregnant women who subsequently developed GDM. Osteocalcin, pGCD59, MDA, GPA, microRNA-16-5p, -17-5p and -20a-5p demonstrated higher levels in the serum of GDM-women compared to non-GDM while SHBG, Irisin and FSTL3 demonstrated lower levels. No association was found between YKL-40 serum levels and the early identification of women at risk for GDM. Conclusions: Several potential biomarkers with promising results relating to GDM predictive value have been explored in the blood of pregnant women during early pregnancy. However, currently, an ideal biomarker does not exist. As a result, further research is needed on this topic. | URI: | https://hdl.handle.net/20.500.14279/31273 | ISSN: | 25852906 | DOI: | 10.18332/ejm/172397 | Type: | Article | Affiliation : | Iasis Private Hospital Cyprus University of Technology University of West Attica |
Publication Type: | Peer Reviewed |
Appears in Collections: | Άρθρα/Articles |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Article.pdf | 70.49 kB | Adobe PDF | View/Open |
CORE Recommender
Page view(s)
86
Last Week
0
0
Last month
5
5
checked on Dec 3, 2024
Download(s)
58
checked on Dec 3, 2024
Google ScholarTM
Check
Altmetric
Items in KTISIS are protected by copyright, with all rights reserved, unless otherwise indicated.